NAPSA Polyclonal Antibody

• Background :

  The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.

• Description :

  This is a NAPSA Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only.

• Synonyms :

  Asp 4, ASP4, Aspartyl protease 4, KAP, Kdap, Kidney derived aspartic protease like protein, NAP1, NAPA, Napsa, NAPSA, Napsin 1, napsin A aspartic peptidase, Napsin A precursor, Napsin-1, Napsin-A, Pronapsin A, SNAPA, TA01/TA02

• Swiss Prot :

  O96009

• Accession Number :

  BC017842

• Reactivity :

  Human, Mouse

• Immunogen :

  Recombinant protein of human NAPSA

• Clonality :

  Polyclonal

• Conjugation :

  Unconjugated

• Type :

  Polyclonal Antibody

• Applications :

  WB, IHC, ELISA

• Purification Method :

  Affinity purification

• Assay Type :

  Antibody

• Concentration :

  0.6 mg/mL

• Dilution :

  WB 1:500-1:2000, IHC 1:50-1:200

• Buffer :

  PBS with 0.05% sodium azide and 50% glycerol, PH7.4

• Storage Conditions :

  Store at -20°C. Avoid freeze / thaw cycles.

• Calculated Molecular Weight :

  45 kDa

• Host or Source :

  Rabbit

• Isotype :

  IgG